SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-18-001789
Filing Date
2018-03-08
Accepted
2018-03-08 17:17:45
Documents
4
Period of Report
2018-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_030818.htm 8-K 22533
2 EXHIBIT 10.3 exh_103.htm EX-10.3 90537
3 EXHIBIT 10.4 exh_104.htm EX-10.4 19601
4 EXHIBIT 99.1 exh_991.htm EX-99.1 10365
  Complete submission text file 0001171843-18-001789.txt   144462
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 18677440
SIC: 3841 Surgical & Medical Instruments & Apparatus